AFFIMED N V's ticker is AFMD and the CUSIP is N01045108. A total of 80 filers reported holding AFFIMED N V in Q2 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,875 | -15.8% | 79,254 | +5.4% | 0.00% | -100.0% |
| Q2 2023 | $44,974 | +39.0% | 75,183 | +188.1% | 0.00% | 0.0% |
| Q4 2022 | $32,363 | +1.1% | 26,099 | +67.3% | 0.00% | 0.0% |
| Q3 2022 | $32,000 | -15.8% | 15,599 | +13.9% | 0.00% | – |
| Q4 2019 | $38,000 | -72.1% | 13,693 | -86.9% | 0.00% | -100.0% |
| Q4 2017 | $136,000 | – | 104,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Public Equity Management, LLC | 3,209,013 | $6,578,000 | 0.40% |
| Telemetry Investments, L.L.C. | 367,067 | $752,000 | 0.35% |
| NEA Management Company, LLC | 3,888,888 | $7,972,000 | 0.29% |
| DAFNA Capital Management LLC | 92,500 | $190,000 | 0.14% |
| Tekla Capital Management LLC | 1,405,324 | $2,881,000 | 0.11% |
| Perceptive Advisors | 668,214 | $1,369,000 | 0.07% |
| MUHLENKAMP & CO INC | 72,786 | $149,000 | 0.05% |
| Orbimed Advisors | 1,799,700 | $3,689,000 | 0.04% |
| MOORE CAPITAL MANAGEMENT, LP | 250,000 | $513,000 | 0.02% |
| Baker Brothers Advisors | 400,000 | $820,000 | 0.01% |